Suchergebnisse - (Person:"Wu, Yanfang")

PubPharm (5)

1

Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization

enthalten in: Medicina (Kaunas, Lithuania) | 2022

von Wu, Y. | Zheng, S. | Zhang, Z. | +8

2

Efficacy of Transarterial Chemoembolization Combined with Molecular Targeted Agents for Unresectable Hepatocellular Carcinoma : A Network Meta-Analysis

enthalten in: Cancers | 2022

von Zhang, Z. | Wu, Y. | Zheng, T. | +7

3

Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization

enthalten in: Medicina (Kaunas, Lithuania) | 2022

von Chen, G. | Chen, H. | Huang, X. | +9

4

Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma

enthalten in: Frontiers in genetics | 2021

von Zheng, S. | Xie, X. | Guo, X. | +6

5

Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma

enthalten in: Frontiers in genetics | 2021

von Zheng, S. | Liu, L. | Xue, T. | +6

1
[1]